Analysts And Doctors Predict Continued Malaise In U.S. ICD Market
This article was originally published in The Gray Sheet
Executive Summary
The U.S. implantable defibrillator market will remain stagnant for the foreseeable future, while overseas demand for the devices will stay strong, according to a report from Morgan Stanley's device industry analysts